BiotechTube

ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pertussis

Conditions

Pertussis, Tetanus, Diphtheria

Trial Timeline

May 1, 2006 → Dec 1, 2008

NCT ID
NCT00319553

About ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed

ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed is a approved stage product being developed by Sanofi for Pertussis. The current trial status is completed. This product is registered under clinical trial identifier NCT00319553. Target conditions include Pertussis, Tetanus, Diphtheria.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00319553ApprovedCompleted

Competing Products

16 competing products in Pertussis

See all competitors
ProductCompanyStageHype Score
Adacel®SanofiApproved
84
aP booster + TdaP booster + Licensed TdaP booster (Boostrix®)NovartisPhase 1
33
Boostrix + Placebo (Saline)NovartisApproved
85
Acellular pertussis vaccine + Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed) + Licensed TdaP booster vaccine + Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)NovartisPhase 1
33
Tetanus Toxoid, acellular pertussis, diphtheria toxoidSanofiPre-clinical
22
COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®)SanofiApproved
84
(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular PertussisSanofiPhase 1/2
40
DT5aP-IPV-Hib 5-component Pertussis vaccine + Infanrix® -IPV+HibSanofiPhase 3
76
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV + Hepatitis B vaccineSanofiPhase 2
51
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) + DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b) + Inactivated Poliomyelitis Vaccine + Poliomyelitis Vaccine bivalent types 1 and 3 + Human Rotavirus, live attenuated + Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)SanofiPhase 3
76
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis VaccineSanofiApproved
84
Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) + Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)SanofiApproved
84
Pentacel® (DTaP-IPV/Hib) + Other Pertussis VaccinesSanofiPre-clinical
22
DTaP-IPV combined vaccine + DTaP vaccineSanofiPhase 3
76
ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + DECAVAC®: Tetanus and Diphtheria Toxoids AdsorbedSanofiApproved
84
Tetanus and diphtheria toxoids and acellular pertussisSanofiPre-clinical
22

Other Products from Sanofi

Adacel®Approved
84
LACTIC ACID(ND)Approved
84
DupilumabApproved
84
glatiramer acetateApproved
84
INSULIN GLULISINE + INSULIN GLARGINEApproved
84